Earnings Feed
Sign Up
Home/Insiders/McKinley Edward J
ME
SEC Insider//CIK 0001306143

McKinley Edward J

CIK 00013061432 companiesBOULDER, CO
SEC Profile

Transactions

50

Companies

2

Filings

3

CIK

0001306143

Recent Transactions

50 trades
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2020-06-04+40,138→ 40,138 total
  • Purchase
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21$13.00/sh+79,857→ 260,730 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+32,320→ 180,873 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+77,211→ 148,553 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+35,671→ 35,671 total
  • Conversion
    Clovis Oncology, Inc.

    Series A-2 Convertible Preferred Stock

    2011-11-21−103,448→ 0 total
  • Conversion
    Clovis Oncology, Inc.

    Series A-1 Convertible Preferred Stock

    2011-11-21−103,448→ 0 total
  • Conversion
    Clovis Oncology, Inc.

    Convertible Promissory Notes

    2011-11-21→ 0 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+35,671→ 71,342 total
  • Conversion
    Clovis Oncology, Inc.

    Series B Convertible Preferred Stock

    2011-11-21−223,914→ 0 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+32,320→ 180,873 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+35,671→ 71,342 total
  • Conversion
    Clovis Oncology, Inc.

    Series A-2 Convertible Preferred Stock

    2011-11-21−103,448→ 0 total
  • Conversion
    Clovis Oncology, Inc.

    Series B Convertible Preferred Stock

    2011-11-21−223,914→ 0 total
  • Purchase
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21$13.00/sh+79,857→ 260,730 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+77,211→ 148,553 total
  • Conversion
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21+35,671→ 35,671 total
  • Conversion
    Clovis Oncology, Inc.

    Series A-1 Convertible Preferred Stock

    2011-11-21−103,448→ 0 total
  • Conversion
    Clovis Oncology, Inc.

    Convertible Promissory Notes

    2011-11-21→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−7,500→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−7,500→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−7,500→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−25,000→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Common Stock

    2008-03-07−110,000→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−5,000→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Common Stock

    2008-03-07−110,000→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−25,000→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−5,000→ 0 total
  • Disposition to Issuer
    PHARMION CORP

    Stock Option (right to buy)

    2008-03-07−7,500→ 0 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.03/sh+300→ 86,600 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.07/sh+920→ 87,920 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.09/sh+80→ 88,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.04/sh+400→ 87,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.30/sh+2,000→ 90,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$18.96/sh+300→ 85,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.01/sh+200→ 86,200 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.35/sh+4,000→ 94,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.01/sh+200→ 86,200 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.09/sh+80→ 88,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.07/sh+920→ 87,920 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.04/sh+400→ 87,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$18.96/sh+300→ 85,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.02/sh+100→ 86,300 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.00/sh+1,000→ 86,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$18.90/sh+1,000→ 83,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$18.95/sh+1,700→ 84,700 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$18.95/sh+1,700→ 84,700 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.00/sh+1,000→ 86,000 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$19.03/sh+300→ 86,600 total
  • Purchase
    PHARMION CORP

    Common Stock

    2006-05-01$18.90/sh+1,000→ 83,000 total

Companies

2

Recent Filings

3

Address

C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100

BOULDER, CO, 80301

View on SEC.gov